Ligand with Two Modes of Interaction with the Dopamine D2 Receptor-An Induced-Fit Mechanism of Insurmountable Antagonism




Agren, Richard
Zeberg, Hugo
Stepniewski, Tomasz Maciej
Free, R. Benjamin
Reilly, Sean W.
Luedtke, Robert R.
Arhem, Peter
Ciruela, Francisco
Sibley, David R.
Mach, Robert H.


0000-0001-8469-2371 (Luedtke, Robert R.)

Journal Title

Journal ISSN

Volume Title


ACS Publications


A solid understanding of the mechanisms governing ligand binding is crucial for rational design of therapeutics targeting the dopamine D2 receptor (D2R). Here, we use G protein-coupled inward rectifier potassium (GIRK) channel activation in Xenopus oocytes to measure the kinetics of D2R antagonism by a series of aripiprazole analogues, as well as the recovery of dopamine (DA) responsivity upon washout. The aripiprazole analogues comprise an orthosteric and a secondary pharmacophore and differ by the length of the saturated carbon linker joining these two pharmacophores. Two compounds containing 3- and 5-carbon linkers allowed for a similar extent of recovery from antagonism in the presence of 1 or 100 muM DA (>25 and >90% of control, respectively), whereas recovery was less prominent ( approximately 20%) upon washout of the 4-carbon linker compound, SV-III-130, both with 1 and 100 muM DA. Prolonging the coincubation time with SV-III-130 further diminished recovery. Curve-shift experiments were consistent with competition between SV-III-130 and DA. Two mutations in the secondary binding pocket (V91A and E95A) of D2R decreased antagonistic potency and increased recovery from SV-III-130 antagonism, whereas a third mutation (L94A) only increased recovery. Our results suggest that the secondary binding pocket influences recovery from inhibition by the studied aripiprazole analogues. We propose a mechanism, supported by in silico modeling, whereby SV-III-130 initially binds reversibly to the D2R, after which the drug-receptor complex undergoes a slow transition to a second ligand-bound state, which is dependent on secondary binding pocket integrity and irreversible during the time frame of our experiments.



Ågren, R., Zeberg, H., St?pniewski, T. M., Free, R. B., Reilly, S. W., Luedtke, R. R., Århem, P., Ciruela, F., Sibley, D. R., Mach, R. H., Selent, J., Nilsson, J., & Sahlholm, K. (2020). Ligand with Two Modes of Interaction with the Dopamine D2 Receptor-An Induced-Fit Mechanism of Insurmountable Antagonism. ACS chemical neuroscience, 11(19), 3130-3143.


© 2020 American Chemical Society


Attribution 4.0 International (CC BY 4.0)